Atreca, Inc. - Class A Common Stock (NQ:BCEL)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Mar 18, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Atreca, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 Next >

Atreca Announces Agreement to Terminate Lease and Departure of Chief Financial Officer Herb Cross

September 21, 2023

From Atreca, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

August 16, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 14, 2023 ↗

August 14, 2023

Via Benzinga

Analyst Expectations for Atreca's Future ↗

June 05, 2023

Via Benzinga

Recap: Atreca Q1 Earnings ↗

May 10, 2023

Via Benzinga

Why Maxeon Solar Technologies Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

August 11, 2023

Gainers Amyris, Inc. (NASDAQ: AMRS) shares jumped 179.1% to $0.1839. Amyris shares dipped over 80% on Thursday after the company announced it filed for Chapter 11 bankruptcy.

Via Benzinga

Topics Bankruptcy

12 Health Care Stocks Moving In Friday's Intraday Session ↗

August 11, 2023

Via Benzinga

The Latest Analyst Ratings for Atreca ↗

March 30, 2023

Via Benzinga

Preview: Atreca's Earnings ↗

March 28, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 11, 2023 ↗

August 11, 2023

Via Benzinga

Atreca Reports Second Quarter 2023 Financial Results and Announces Corporate Restructuring

August 10, 2023

From Atreca, Inc.

Via GlobeNewswire

3 Penny Stocks to Catapult You Into the Millionaires’ Club ↗

July 13, 2023

These penny stocks can deliver tremendous upside from their depressed range. Wall Street analysts can back it up!

Via InvestorPlace

Why ToughBuilt Industries Shares Are Trading Lower By Over 46%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

June 21, 2023

Gainers Advanced Health Intelligence Ltd. (NASDAQ: AHI) shares jumped 209.5% to $2.29 after the company signed a Letter of Intention with UAE-Based e-script medicine management company Pharmak...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

June 21, 2023

Via Benzinga

Atreca Presents Data from Ongoing Phase 1b Study of ATRC-101 in Patients with Select Advanced Solid Tumors during Oral Abstract Session at the ASCO 2023 Annual Meeting

June 05, 2023

From Atreca, Inc.

Via GlobeNewswire

Atreca Reports First Quarter 2023 Financial Results and Recent Corporate Developments

May 10, 2023

From Atreca, Inc.

Via GlobeNewswire

Atreca Announces Oral Presentation of ATRC-101 Phase 1b Study Data at ASCO 2023 Annual Meeting

April 26, 2023

From Atreca, Inc.

Via GlobeNewswire

Atreca to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference

April 13, 2023

From Atreca, Inc.

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2023 ↗

March 30, 2023

Via Benzinga

Philip Morris To Rally Over 22%? Here Are 10 Other Analyst Forecasts For Thursday ↗

March 30, 2023

Chardan Capital cut the price target for Synlogic, Inc. (NASDAQ: SYBX) from $7 to $5.5. Chardan Capital analyst Keay Nakae maintained a Buy rating. Synlogic shares gained 2.9% to close at $0.63 on...

Via Benzinga

Atreca Reports Fourth Quarter and Full-Year 2022 Financial Results and ATRC-101 Data Update

March 29, 2023

From Atreca, Inc.

Via GlobeNewswire

Atreca to Host Fourth Quarter and Year End 2022 Conference Call and Webcast on March 29, 2023

March 23, 2023

Call/webcast to feature updates on the discovery platform and pipeline, including updated data from the ongoing Phase 1b trial of ATRC-101

From Atreca, Inc.

Via GlobeNewswire

Atreca to Participate at Cowen’s 43rd Annual Health Care Conference

March 01, 2023

From Atreca, Inc.

Via GlobeNewswire

Why Is T2 Biosystems (TTOO) Stock Down 21% Today? ↗

February 14, 2023

T2 Biosystems (TTOO) stock is falling hard on Tuesday as investors react to a proposed public offering from the company.

Via InvestorPlace

Why Is Atreca (BCEL) Stock Up Today? ↗

February 14, 2023

Atreca (BCEL) stock is getting a boost on Tuesday as the biopharmaceutical company continues a recent rally connected to insider buying.

Via InvestorPlace

Why Fusion Pharmaceuticals Shares Are Trading Higher By 23%; Here Are 20 Stocks Moving Premarket ↗

February 14, 2023

Gainers

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

February 14, 2023

It's time to start another day of trading with a breakdown of the biggest pre-market stock movers investors need to watch for Tuesday!

Via InvestorPlace

Atreca and Xencor to Develop T Cell Engaging Bispecific Antibody Directed Against Novel Solid Tumor Target

February 06, 2023

From Atreca, Inc.

Via GlobeNewswire

Atreca Appoints Philippe Bishop, MD as Chief Medical Officer

January 09, 2023

From Atreca, Inc.

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023 ↗

January 05, 2023

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.